A / A / A

vaccination

MSF medical mobile teams vaccinating Elderly people and frontline Healthcare workers in a nursing home in Tripoli.
Blog post

Covid-19 Reading List : the vaccines special edition

We can all agree that the emergence of Covid-19 vaccine is “an absolutely astonishing development”, but vaccines are unlikely to completely halt the spread of the virus, let alone eradicate it. Yet even without achieving herd immunity, the ability to vaccinate vulnerable people seems to be reducing hospitalizations and deaths from Covid-19. 

MSF provides support to two centres set up in north Marseille to test and refer people testing positive for coronavirus.
Blog post

Communicating and convincing: a humanitarian perspective on the French response to the coronavirus epidemic

In this paper, the two authors examine certain aspects of the French response to the epidemic in the light of the experience of Médecins Sans Frontières (MSF) in that field, primarily with respect to the relationship between the actors of the response and the beneficiaries.

José Rodrigues Emergency Unit (UPA) in Manaus, Brazil, where the Covid situation remains critical.
Blog post

What to think, do and say about the Covid-19 vaccination? 

Blog written by Jean-Hervé Bradol, director of studies at the Crash.

Today, in order to obtain supplies of vaccines against Covid-19, there is neither a major difficulty related to price, nor a major obstacle related to intellectual property rules, nor a deficit in bio-medical research. However, these three topics are generally at the heart of MSF's communication in the area of access to medical care for those in most need. Our discourse must therefore evolve.
With the emergence of worrying variants of the virus present in the early stages of the pandemic and, as a consequence, the need to vaccinate on a global scale as quickly as possible, the world is facing a double challenge: biological engineering and ultra-industrial production – “ultra” echoing the need to produce on a global scale in a short period of time.

Antirétroviraux
Article

Deadly Gaps Persist in New Drug Development for Neglected Diseases

The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts. 

Un homme enfile des gants avant une campagne de vaccination
Blog post

The Last Mile. Can we afford to keep believing in the eradication of polio?

In the 1980s, a global commitment was made to eradicate polio in the wake of the eradication of smallpox. As far as the world health community was concerned, this successful experience made it an example model on which to base future campaigns against infectious diseases.

Buenaventura, un centre de soins
Article

Refusing to accept the death toll from drug-resistant TB

Epidemiological studies estimate that nearly nine million people were suffering from active tuberculosis (TB) in 2010, causing upwards of one and a half million deaths. More than 90% of these deaths took place in low- or middle-income countries, thus reinforcing an old idea that TB and poverty are strongly linked.